Pages that link to "Q81419860"
Jump to navigation
Jump to search
The following pages link to Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis (Q81419860):
Displaying 50 items.
- Next-generation prognostic assessment for diffuse large B-cell lymphoma (Q26796428) (← links)
- Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature (Q26799503) (← links)
- Biology of double-hit B-cell lymphomas (Q26825581) (← links)
- Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab (Q28256567) (← links)
- Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France (Q33560762) (← links)
- Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma (Q34218069) (← links)
- Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements (Q34484838) (← links)
- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. (Q34882773) (← links)
- Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma (Q35128216) (← links)
- B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma (Q35153156) (← links)
- Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases? (Q35384536) (← links)
- Cell of origin of transformed follicular lymphoma (Q36225164) (← links)
- Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC (Q36232304) (← links)
- Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity (Q36439752) (← links)
- Quantitative image analysis in the assessment of diffuse large B-cell lymphoma (Q36757502) (← links)
- Nodal aggressive B-cell lymphomas: a diagnostic approach (Q36763463) (← links)
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. (Q36771814) (← links)
- C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology (Q36784863) (← links)
- Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature (Q36799405) (← links)
- A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). (Q36868708) (← links)
- MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr (Q37006876) (← links)
- Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers (Q37031640) (← links)
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations (Q37246742) (← links)
- MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation (Q37273619) (← links)
- Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge (Q37299272) (← links)
- Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. (Q37301300) (← links)
- Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma (Q37437423) (← links)
- Pitfalls in diagnostic hematopathology -- Part II (Q37633945) (← links)
- Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy (Q37638414) (← links)
- The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas (Q37781972) (← links)
- The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma (Q37785375) (← links)
- Upper aerodigestive tract lymphoma in Taiwan (Q37793659) (← links)
- Double-hit B-cell lymphomas (Q37813897) (← links)
- The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective (Q37863996) (← links)
- Primary High-Grade B-Cell Lymphoma of the Breast with Concurrent IGH-BCL2 and MYC-IGL Translocations in an Adolescent Patient (Q37865013) (← links)
- BCL2 and MYC Dual-Hit Lymphoma/Leukemia (Q37882924) (← links)
- Mechanisms and impacts of chromosomal translocations in cancers (Q38032210) (← links)
- The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma (Q38124735) (← links)
- Validation of break-apart and fusion MYC probes using a digital fluorescence in situ hybridization capture and imaging system (Q38380157) (← links)
- Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. (Q38436671) (← links)
- Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when? (Q38441989) (← links)
- Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas (Q38627352) (← links)
- The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects (Q39221506) (← links)
- A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1. (Q39574938) (← links)
- Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations (Q40009448) (← links)
- IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt's lymphoma (Q40161325) (← links)
- Double-Hit Lymphoma at Second Relapse of Burkitt-Like Lymphoma : A Case Report (Q40323065) (← links)
- Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma (Q40791388) (← links)
- Novel lymphoid neoplasms--the borderland between diffuse large B-cell lymphoma and Burkitt's lymphoma (Q42715153) (← links)
- A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia (Q42940551) (← links)